Calcium in PDB 5b5o: Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Protein crystallography data
The structure of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine, PDB code: 5b5o
was solved by
H.Oki,
Y.Tanaka,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
33.75 /
1.20
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
136.409,
36.060,
95.948,
90.00,
131.09,
90.00
|
R / Rfree (%)
|
16.4 /
18.5
|
Other elements in 5b5o:
The structure of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
(pdb code 5b5o). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine, PDB code: 5b5o:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 5b5o
Go back to
Calcium Binding Sites List in 5b5o
Calcium binding site 1 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:10.7
occ:1.00
|
OE2
|
A:GLU205
|
2.2
|
20.5
|
1.0
|
O
|
A:GLY180
|
2.3
|
11.6
|
1.0
|
O
|
A:LEU184
|
2.3
|
12.7
|
1.0
|
OD2
|
A:ASP202
|
2.3
|
9.6
|
1.0
|
OD1
|
A:ASP179
|
2.3
|
11.3
|
1.0
|
O
|
A:SER182
|
2.4
|
16.2
|
1.0
|
C
|
A:LEU184
|
3.4
|
12.2
|
1.0
|
CG
|
A:ASP202
|
3.5
|
9.0
|
1.0
|
CD
|
A:GLU205
|
3.5
|
15.9
|
1.0
|
CG
|
A:ASP179
|
3.5
|
13.2
|
1.0
|
C
|
A:GLY180
|
3.5
|
12.2
|
1.0
|
C
|
A:SER182
|
3.5
|
17.0
|
1.0
|
N
|
A:LEU184
|
3.8
|
12.8
|
1.0
|
N
|
A:SER182
|
3.9
|
17.3
|
1.0
|
C
|
A:PRO181
|
4.0
|
18.5
|
1.0
|
OD2
|
A:ASP179
|
4.0
|
14.4
|
1.0
|
CA
|
A:LEU184
|
4.1
|
13.6
|
1.0
|
N
|
A:GLY180
|
4.1
|
11.3
|
1.0
|
CB
|
A:ASP202
|
4.2
|
7.5
|
1.0
|
CG
|
A:GLU205
|
4.2
|
13.9
|
1.0
|
C
|
A:GLY183
|
4.3
|
14.8
|
1.0
|
CA
|
A:SER182
|
4.3
|
18.1
|
0.5
|
C
|
A:ASP179
|
4.3
|
13.1
|
1.0
|
CA
|
A:SER182
|
4.3
|
17.9
|
0.5
|
OD1
|
A:ASP202
|
4.3
|
8.4
|
1.0
|
N
|
A:ASP179
|
4.3
|
11.0
|
1.0
|
O
|
A:PRO181
|
4.3
|
22.5
|
1.0
|
OE1
|
A:GLU205
|
4.4
|
14.4
|
1.0
|
CA
|
A:PRO181
|
4.4
|
15.4
|
1.0
|
CB
|
A:LEU184
|
4.4
|
14.5
|
1.0
|
N
|
A:PRO181
|
4.4
|
14.4
|
1.0
|
CA
|
A:GLY180
|
4.4
|
11.7
|
1.0
|
N
|
A:GLY183
|
4.5
|
17.2
|
1.0
|
N
|
A:LEU185
|
4.5
|
11.4
|
1.0
|
CA
|
A:GLY183
|
4.6
|
15.1
|
1.0
|
CA
|
A:ASP179
|
4.6
|
12.2
|
1.0
|
CB
|
A:ASP179
|
4.7
|
13.0
|
1.0
|
O
|
A:ASP179
|
4.7
|
13.7
|
1.0
|
CA
|
A:LEU185
|
4.8
|
9.7
|
1.0
|
O
|
A:GLY183
|
4.9
|
15.7
|
1.0
|
|
Calcium binding site 2 out
of 4 in 5b5o
Go back to
Calcium Binding Sites List in 5b5o
Calcium binding site 2 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:8.4
occ:1.00
|
O
|
A:GLY196
|
2.3
|
7.9
|
1.0
|
O
|
A:HOH425
|
2.3
|
10.8
|
1.0
|
O
|
A:ASN194
|
2.3
|
11.5
|
1.0
|
O
|
A:HOH483
|
2.4
|
10.5
|
1.0
|
O
|
A:ASP162
|
2.4
|
8.6
|
1.0
|
OD1
|
A:ASP198
|
2.4
|
7.5
|
1.0
|
CG
|
A:ASP198
|
3.4
|
7.0
|
1.0
|
C
|
A:GLY196
|
3.5
|
8.1
|
1.0
|
C
|
A:ASP162
|
3.5
|
8.0
|
1.0
|
C
|
A:ASN194
|
3.5
|
11.7
|
1.0
|
OD2
|
A:ASP198
|
3.9
|
8.7
|
1.0
|
C
|
A:TYR195
|
3.9
|
8.8
|
0.5
|
O
|
A:TYR195
|
4.0
|
7.0
|
0.5
|
C
|
A:TYR195
|
4.0
|
10.5
|
0.5
|
N
|
A:GLY196
|
4.0
|
9.1
|
1.0
|
O
|
A:ALA161
|
4.2
|
9.9
|
1.0
|
N
|
A:ASP198
|
4.2
|
7.0
|
1.0
|
O
|
A:TYR195
|
4.3
|
9.7
|
0.5
|
CA
|
A:GLY196
|
4.3
|
8.5
|
1.0
|
CA
|
A:ASP162
|
4.3
|
8.6
|
1.0
|
CA
|
A:TYR195
|
4.3
|
10.6
|
0.5
|
O
|
A:HOH421
|
4.3
|
19.6
|
1.0
|
CA
|
A:TYR195
|
4.4
|
12.1
|
0.5
|
O
|
A:HOH614
|
4.4
|
24.4
|
1.0
|
N
|
A:TYR195
|
4.4
|
11.5
|
0.5
|
O
|
A:GLY192
|
4.4
|
12.1
|
1.0
|
N
|
A:TYR195
|
4.4
|
12.6
|
0.5
|
N
|
A:GLY197
|
4.5
|
7.2
|
1.0
|
N
|
A:ILE163
|
4.5
|
7.8
|
1.0
|
CA
|
A:ASN194
|
4.5
|
14.6
|
1.0
|
N
|
A:ASN194
|
4.5
|
13.5
|
1.0
|
CA
|
A:GLY197
|
4.6
|
7.7
|
1.0
|
CB
|
A:ASP198
|
4.6
|
7.6
|
1.0
|
C
|
A:GLY197
|
4.7
|
6.1
|
1.0
|
O
|
A:HOH424
|
4.7
|
14.0
|
1.0
|
N
|
A:MET164
|
4.7
|
7.0
|
1.0
|
CA
|
A:ILE163
|
4.7
|
6.9
|
1.0
|
CG
|
A:MET164
|
4.7
|
8.1
|
1.0
|
CA
|
A:ASP198
|
4.8
|
7.0
|
1.0
|
C
|
A:PRO193
|
4.8
|
12.8
|
1.0
|
CH2
|
A:TRP113
|
4.9
|
13.2
|
1.0
|
|
Calcium binding site 3 out
of 4 in 5b5o
Go back to
Calcium Binding Sites List in 5b5o
Calcium binding site 3 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca303
b:10.7
occ:1.00
|
OE2
|
B:GLU205
|
2.3
|
16.1
|
1.0
|
OD2
|
B:ASP202
|
2.3
|
9.7
|
1.0
|
O
|
B:LEU184
|
2.3
|
12.6
|
1.0
|
O
|
B:GLY180
|
2.3
|
12.4
|
1.0
|
O
|
B:SER182
|
2.3
|
14.4
|
1.0
|
OD1
|
B:ASP179
|
2.4
|
10.7
|
1.0
|
CG
|
B:ASP202
|
3.4
|
8.1
|
1.0
|
C
|
B:LEU184
|
3.4
|
11.1
|
1.0
|
C
|
B:SER182
|
3.5
|
15.8
|
1.0
|
CD
|
B:GLU205
|
3.5
|
13.9
|
1.0
|
C
|
B:GLY180
|
3.5
|
13.3
|
1.0
|
CG
|
B:ASP179
|
3.5
|
12.2
|
1.0
|
N
|
B:SER182
|
3.8
|
15.4
|
1.0
|
N
|
B:LEU184
|
3.9
|
11.1
|
1.0
|
C
|
B:PRO181
|
4.0
|
15.5
|
1.0
|
OD2
|
B:ASP179
|
4.1
|
15.4
|
1.0
|
N
|
B:GLY180
|
4.1
|
12.7
|
1.0
|
CA
|
B:LEU184
|
4.1
|
11.2
|
1.0
|
CB
|
B:ASP202
|
4.2
|
8.1
|
1.0
|
CA
|
B:SER182
|
4.2
|
16.8
|
1.0
|
OE1
|
B:GLU205
|
4.3
|
14.6
|
1.0
|
C
|
B:GLY183
|
4.3
|
12.2
|
1.0
|
N
|
B:ASP179
|
4.3
|
11.4
|
1.0
|
OD1
|
B:ASP202
|
4.3
|
8.8
|
1.0
|
C
|
B:ASP179
|
4.3
|
13.5
|
1.0
|
CA
|
B:PRO181
|
4.4
|
14.2
|
1.0
|
CG
|
B:GLU205
|
4.4
|
13.4
|
1.0
|
N
|
B:PRO181
|
4.4
|
14.5
|
1.0
|
CA
|
B:GLY180
|
4.4
|
13.3
|
1.0
|
O
|
B:PRO181
|
4.4
|
17.1
|
1.0
|
N
|
B:GLY183
|
4.5
|
14.2
|
1.0
|
N
|
B:LEU185
|
4.5
|
9.8
|
1.0
|
CB
|
B:LEU184
|
4.5
|
12.3
|
1.0
|
CA
|
B:ASP179
|
4.6
|
11.9
|
1.0
|
CA
|
B:GLY183
|
4.6
|
13.9
|
1.0
|
CB
|
B:ASP179
|
4.7
|
13.0
|
1.0
|
CA
|
B:LEU185
|
4.7
|
9.6
|
1.0
|
O
|
B:ASP179
|
4.8
|
13.9
|
1.0
|
O
|
B:GLY183
|
4.8
|
14.1
|
1.0
|
|
Calcium binding site 4 out
of 4 in 5b5o
Go back to
Calcium Binding Sites List in 5b5o
Calcium binding site 4 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca304
b:8.9
occ:1.00
|
O
|
B:GLY196
|
2.3
|
9.6
|
1.0
|
O
|
B:ASP162
|
2.3
|
8.3
|
1.0
|
O
|
B:ASN194
|
2.3
|
10.5
|
1.0
|
O
|
B:HOH460
|
2.4
|
10.4
|
1.0
|
O
|
B:HOH441
|
2.4
|
10.7
|
1.0
|
OD1
|
B:ASP198
|
2.4
|
8.8
|
1.0
|
CG
|
B:ASP198
|
3.4
|
8.8
|
1.0
|
C
|
B:GLY196
|
3.5
|
9.1
|
1.0
|
C
|
B:ASP162
|
3.5
|
8.9
|
1.0
|
C
|
B:ASN194
|
3.5
|
11.1
|
1.0
|
C
|
B:TYR195
|
3.8
|
10.0
|
1.0
|
O
|
B:HOH418
|
3.9
|
15.0
|
1.0
|
OD2
|
B:ASP198
|
3.9
|
9.4
|
1.0
|
N
|
B:GLY196
|
3.9
|
10.6
|
1.0
|
O
|
B:TYR195
|
4.0
|
9.9
|
1.0
|
O
|
B:ALA161
|
4.2
|
8.7
|
1.0
|
N
|
B:ASP198
|
4.2
|
8.6
|
1.0
|
CA
|
B:GLY196
|
4.2
|
10.5
|
1.0
|
CA
|
B:ASP162
|
4.3
|
8.8
|
1.0
|
O
|
B:HOH576
|
4.3
|
29.8
|
1.0
|
N
|
B:TYR195
|
4.4
|
11.2
|
1.0
|
CA
|
B:TYR195
|
4.4
|
11.3
|
1.0
|
O
|
B:HOH581
|
4.4
|
40.6
|
1.0
|
CA
|
B:ASN194
|
4.4
|
12.7
|
1.0
|
O
|
B:GLY192
|
4.4
|
11.8
|
1.0
|
N
|
B:ILE163
|
4.5
|
7.5
|
1.0
|
N
|
B:GLY197
|
4.5
|
8.7
|
1.0
|
N
|
B:ASN194
|
4.5
|
13.5
|
1.0
|
CB
|
B:ASP198
|
4.6
|
8.3
|
1.0
|
CA
|
B:ILE163
|
4.6
|
7.7
|
1.0
|
CA
|
B:GLY197
|
4.6
|
9.1
|
1.0
|
N
|
B:MET164
|
4.7
|
7.9
|
1.0
|
O
|
B:HOH434
|
4.7
|
18.4
|
1.0
|
C
|
B:GLY197
|
4.7
|
8.5
|
1.0
|
CA
|
B:ASP198
|
4.8
|
7.9
|
1.0
|
C
|
B:PRO193
|
4.8
|
13.9
|
1.0
|
CG
|
B:MET164
|
4.9
|
8.6
|
1.0
|
CH2
|
B:TRP113
|
4.9
|
13.3
|
1.0
|
O
|
B:PRO193
|
5.0
|
14.5
|
1.0
|
|
Reference:
H.Nara,
A.Kaieda,
K.Sato,
T.Naito,
H.Mototani,
H.Oki,
Y.Yamamoto,
H.Kuno,
T.Santou,
N.Kanzaki,
J.Terauchi,
O.Uchikawa,
M.Kori.
Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (Mmp)-13 Inhibitors with A 1,2,4-Triazol-3-Yl Moiety As A Zinc Binding Group Using A Structure-Based Design Approach J. Med. Chem. V. 60 608 2017.
ISSN: ISSN 1520-4804
PubMed: 27966948
DOI: 10.1021/ACS.JMEDCHEM.6B01007
Page generated: Sun Jul 14 16:49:58 2024
|